ArticleThe journal of histochemistry and cytochemistry : official journal of the Histochemistry Society2013

High expression of survivin is prognostic of shorter survival but not predictive of adjuvant gemcitabine benefit in patients with resected pancreatic adenocarcinoma.

Hao Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.